Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M95.3Revenue $M40.0Net Margin (%)5.3Z-Score16.2
Enterprise Value $M2.7EPS $0.4Operating Margin %-3.0F-Score5
P/E(ttm))51.6Cash Flow Per Share $0.1Pre-tax Margin (%)4.9Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %0Quick Ratio25.8Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %0Current Ratio29.3Lower Leverage y-yY
Price/Cash Flow57.2y-y EBITDA Growth Rate %-92.7ROA % (ttm)1.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)1.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M9.5ROI % (ttm)3.9Gross Margin Increase y-yN

Gurus Latest Trades with GENC

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
GENCJohn Keeley 2010-03-31 Sold Out $6.9 - $7.8
$ 10.0127%Sold Out0
GENCJohn Keeley 2009-09-30 Buy $6.38 - $8.35
$ 10.0128%New holding30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GENC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

GENC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LYONS JEANNE MSecretary 2015-03-16Sell985$9.782.25view
LYONS JEANNE MSecretary 2015-03-16Sell985$9.782.25view
Houtkin Sherry10% Owner 2014-12-08Sell2,948$9.722.88view
Houtkin Sherry10% Owner 2014-12-02Sell5,000$9.930.7view
Houtkin Sherry10% Owner 2014-11-25Sell200,000$9.258.11view
Houtkin Sherry10% Owner 2014-09-04Sell29$10.19-1.86view
Houtkin Sherry10% Owner 2014-09-02Sell5,000$10.18-1.77view
Houtkin Sherry10% Owner 2014-08-26Sell5,346$10.23-2.25view
Houtkin Sherry10% Owner 2014-08-21Sell8,392$10.18-1.77view
LYONS JEANNE MSecretary 2014-03-14Sell265$10.9-8.26view

Press Releases about GENC :

    Quarterly/Annual Reports about GENC:

    News about GENC:

    Articles On GuruFocus.com
    Winning with the Net Current Asset Value Approach to Stocks Sep 04 2013 
    comment on GENC Aug 24 2012 
    comment on GENC Aug 13 2012 
    comment on GENC Jul 11 2012 
    comment on GENC Jul 11 2012 
    comment on GENC Jul 11 2012 
    Ben Graham Net-Net Newsletter: TSR (TSRI) One Year Later Apr 09 2012 
    “Assign Yourself the Right Story” Mar 05 2012 
    comment on GENC Mar 05 2012 
    Ben Graham Net-Net Newsletter: Gencor (GENC) One Year Later Feb 29 2012 

    More From Other Websites
    Report Pursuant to Section 28a of the Danish Securities Trading Act Mar 26 2015
    Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to two Board... Mar 26 2015
    Passing of Genmab A/S' Annual General Meeting Mar 26 2015
    Genmab Acquires Antibody Assets from iDD Biotech Mar 18 2015
    Genmab Retains Partial Rights for HuMax-TAC-ADC — Will Not Exercise Co-development Right Mar 16 2015
    Articles of Association for Genmab A/S Mar 13 2015
    Report Pursuant to Section 28a of the Danish Securities Trading Act Mar 12 2015
    Report Pursuant to Section 28a of the Danish Securities Trading Act Mar 11 2015
    Capital Increase in Genmab as a Result of Employee Warrant Exercise and Projection of Improved Cash... Mar 11 2015
    GENCOR INDUSTRIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Mar 06 2015
    Genmab A/S Summons Annual General Meeting Mar 03 2015
    Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective Mar 02 2015
    Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology Feb 19 2015
    GENCOR INDUSTRIES INC Financials Feb 13 2015
    10-Q for Gencor Industries, Inc. Feb 08 2015
    Gencor Releases First Quarter Fiscal 2015 Results Feb 06 2015
    GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 06 2015
    GENCOR INDUSTRIES INC Files SEC form 10-Q, Quarterly Report Feb 06 2015
    Major Shareholder Announcement Feb 04 2015
    Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple... Feb 04 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial